ArticleInternational journal of nanomedicine2019

RGDV-modified gemcitabine: a nano-medicine capable of prolonging half-life, overcoming resistance and eliminating bone marrow toxicity of gemcitabine.

Wenchao Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.